Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Cited In for PubMed (Select 11130523)

2.

Efficacy of a brief multifactorial adherence-based intervention in reducing blood pressure: a randomized clinical trial.

Leiva A, Aguiló A, Fajó-Pascual M, Moreno L, Martín MC, Garcia EM, Duro RE, Serra F, Dagosto P, Iglesias-Iglesias AA, Company RM, Yañez A, Llobera J.

Patient Prefer Adherence. 2014 Dec 5;8:1683-90. doi: 10.2147/PPA.S66927. eCollection 2014.

3.

Level of blood pressure control among hypertensive patients on follow-up in a regional referral hospital in Central Kenya.

Mutua EM, Gitonga MM, Mbuthia B, Muiruri N, Cheptum JJ, Maingi T.

Pan Afr Med J. 2014 Aug 5;18:278. doi: 10.11604/pamj.2014.18.278.4308. eCollection 2014.

4.

Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.

ENOS Trial Investigators, Bath PM, Woodhouse L, Scutt P, Krishnan K, Wardlaw JM, Bereczki D, Sprigg N, Berge E, Beridze M, Caso V, Chen C, Christensen H, Collins R, El Etribi A, Laska AC, Lees KR, Ozturk S, Phillips S, Pocock S, de Silva HA, Szatmari S, Utton S.

Lancet. 2015 Feb 14;385(9968):617-28. doi: 10.1016/S0140-6736(14)61121-1. Epub 2014 Oct 21. Erratum in: Lancet. 2015 Feb 14;385(9968):606.

5.

Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression.

Maharjan S, Mopidevi B, Kaw MK, Puri N, Kumar A.

Physiol Genomics. 2014 Dec 15;46(24):860-5. doi: 10.1152/physiolgenomics.00084.2014. Epub 2014 Oct 28.

PMID:
25351194
6.

Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.

Patel RS, Sharma KH, Kamath NA, Patel NH, Thakkar AM.

Indian J Pharmacol. 2014 Sep-Oct;46(5):485-9. doi: 10.4103/0253-7613.140577.

7.

Evaluation of thiazide diuretic use as preferred therapy in uncomplicated essential hypertension patients.

Greene RS, Escobar Quinones M, Edwards KL.

Pharm Pract (Granada). 2007 Jul;5(3):130-4.

8.

An evaluation of a clinical pharmacy-directed intervention on blood pressure control.

Kicklighter CE, Nelson KM, Humphries TL, Delate T.

Pharm Pract (Granada). 2006;4(3):110-6.

9.

Perindopril for improving cardiovascular events.

DiNicolantonio JJ, O'Keefe JH.

Vasc Health Risk Manag. 2014 Aug 30;10:539-48. doi: 10.2147/VHRM.S68384. eCollection 2014. No abstract available.

10.

Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study.

Sørensen IF, Vazquez AI, Irvin MR, Sørensen P, Davis BR, Ford CE, Boerwinkle E, Eckfeldt JH, Arnett DK.

Pharmacogenet Genomics. 2014 Nov;24(11):556-63. doi: 10.1097/FPC.0000000000000088.

PMID:
25171760
11.

Socioeconomic inequality in salt intake in Britain 10 years after a national salt reduction programme.

Ji C, Cappuccio FP.

BMJ Open. 2014 Aug 14;4(8):e005683. doi: 10.1136/bmjopen-2014-005683. Erratum in: BMJ Open. 2014;4(12):e005683corr1.

12.

Hypertension management: an update.

Nguyen Q, Dominguez J, Nguyen L, Gullapalli N.

Am Health Drug Benefits. 2010 Jan;3(1):47-56.

13.

2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations.

Krakoff LR, Gillespie RL, Ferdinand KC, Fergus IV, Akinboboye O, Williams KA, Walsh MN, Bairey Merz CN, Pepine CJ.

J Am Coll Cardiol. 2014 Jul 29;64(4):394-402. doi: 10.1016/j.jacc.2014.06.014. Review.

PMID:
25060376
14.

Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study.

Chia YC, Ching SM.

BMC Fam Pract. 2014 Jul 5;15:131. doi: 10.1186/1471-2296-15-131.

15.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; SPRINT Study Research Group.

Clin Trials. 2014 Oct;11(5):532-46. doi: 10.1177/1740774514537404. Epub 2014 Jun 5.

PMID:
24902920
16.

Frequency of cardiovascular events in patients treated with anti hypertensive agents: A cohort study based on claims data generated by primary care practice.

Russo P, Capone A, Sturani A, Degli Esposti E.

Curr Ther Res Clin Exp. 2004 Sep;65(5):398-412. doi: 10.1016/j.curtheres.2004.10.003.

17.

Relaxation of rat aorta by farrerol correlates with potency to reduce intracellular calcium of VSMCs.

Qin X, Hou X, Zhang M, Liang T, Zhi J, Han L, Li Q.

Int J Mol Sci. 2014 Apr 17;15(4):6641-56. doi: 10.3390/ijms15046641.

18.

Dietary sodium and potassium intake is not associated with elevated blood pressure in US adults with no prior history of hypertension.

Sharma S, McFann K, Chonchol M, Kendrick J.

J Clin Hypertens (Greenwich). 2014 Jun;16(6):418-23. doi: 10.1111/jch.12312. Epub 2014 Apr 11.

PMID:
24720647
19.

Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?

Armaganijan L, Staico R, Moraes A, Abizaid A, Moreira D, Amodeo C, Sousa M, Borelli F, Armaganijan D, Sousa JE, Sousa A.

Arq Bras Cardiol. 2014 Apr;102(4):355-63. doi: 10.5935/abc.20140034. Epub 2014 Feb 17. English, Portuguese.

20.

Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients?

Shema-Didi L, Kristal B, Sela S, Geron R, Ore L.

Nutr J. 2014 Mar 4;13:18. doi: 10.1186/1475-2891-13-18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk